Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy.

Lu, Mingdong; Zhao, Bin; Liu, Mengshan; Wu, Le; Li, Yingying; Zhai, Yingna; Shen, Xian

Lu, Mingdong; Zhao, Bin; Liu, Mengshan; Wu, Le; Li, Yingying; Zhai, Yingna; Shen, Xian.

Afiliação

Lu M; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Zhao B; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. doctorbinzhao@126.com.
Liu M; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Wu L; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Li Y; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Zhai Y; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Shen X; The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. doctorxianshen@126.com.

NPJ Precis Oncol ; 5(1): 51, 2021 Jun 14.

Article em En | MEDLINE | ID: mdl-34127768

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google